Related Experiment Video
Updated: May 30, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo
Stefano Campaner1, Fabio Spreafico, Thomas Burgold
1Department of Experimental Oncology, European Institute of Oncology at the IFOM-IEO-Campus, Via Adamello 16, 20139 Milan, Italy.
Abstract:
p53 is the central regulator of cell fate following genotoxic stress and oncogene activation. Its activity is controlled by several posttranslational modifications. Originally defined as a critical layer of p53 regulation in human cell lines, p53 lysine methylation by Set7/9 (also called Setd7) was proposed to fulfill a similar function in vivo in the mouse, promoting p53 acetylation, stabilization, and activation upon DNA damage (Kurash et al., 2008). We tested the physiological relevance of this circuit in an independent Set7/9 knockout mouse strain. Deletion of Set7/9 had no effect on p53-dependent cell-cycle arrest or apoptosis following sublethal or lethal DNA damage induced by radiation or genotoxic agents. Set7/9 was also dispensable for p53 acetylation following irradiation. c-myc oncogene-induced apoptosis was also independent of Set7/9, and analysis of p53 target genes showed that Set7/9 is not required for the p53-dependent gene expression program. Our data indicate that Set7/9 is dispensable for p53 function in the mouse.
Insights
The enzyme Set7/9 (also called Setd7) is not essential for p53 protein function in mice. Our study found Set7/9 is dispensable for p53-mediated cell cycle arrest and apoptosis following DNA damage.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- p53 is a crucial regulator of cell fate in response to DNA damage and oncogene activation.
- Posttranslational modifications, including lysine methylation by Set7/9 (Setd7), control p53 activity.
- Previous studies suggested Set7/9-mediated methylation promotes p53 acetylation, stabilization, and activation in human cells.
Purpose of the Study:
- To investigate the physiological relevance of Set7/9-mediated p53 regulation in vivo.
- To determine if Set7/9 is essential for p53-dependent responses in mice.
Main Methods:
- Utilized an independent Set7/9 knockout mouse strain.
- Assessed p53-dependent cell-cycle arrest and apoptosis following DNA damage (radiation, genotoxic agents).
- Analyzed p53 acetylation, c-myc oncogene-induced apoptosis, and p53 target gene expression.
Main Results:
- Deletion of Set7/9 did not affect p53-dependent cell-cycle arrest or apoptosis after DNA damage.
- Set7/9 was not required for p53 acetylation following irradiation.
- p53-mediated apoptosis induced by c-myc oncogene was independent of Set7/9.
- Set7/9 dispensable for p53-dependent gene expression program.
Conclusions:
- Set7/9 is dispensable for p53 function in mice.
- The proposed role of Set7/9 in promoting p53 acetylation, stabilization, and activation in vivo is not supported by our findings.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

